Skip to main content

Table 4 Differences in clinicopathological factors according to the primary tumor’s SUVmax

From: Preoperative identification of clinicopathological prognostic factors for relapse-free survival in clinical N1 non-small cell lung cancer: a retrospective single center-based study

  Total (n = 60) Primary tumor’s SUVmax P value
High Low
Sex
 Male 46 23 23 1.000
 Female 14 6 8  
Age
 < 70 years 28 14 14 0.7961
 ≥ 70 years 32 15 17  
Histological type
 Adenocarcinoma 27 8 19 0.0108*
 Non-adenocarcinoma 33 21 12  
Tumor size
 ≤ 30 mm 19 3 16 < 0.0001*
 > 30 mm 41 26 15  
CEA
 < 5.0 ng/mL 30 11 19 0.1205
 ≥ 5.0 ng/mL 30 18 12  
Pathological N status ng/mL
 pN0 23 9 14 0.2106
 pN1 22 14 8  
 pN2 15 6 9  
  1. *P < 0.05